Bronstein, Gewirtz & Grossman, LLC Encourages Paragon 28, Inc. (FNA) Stockholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / February 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Bronstein, Gewirtz & Grossman, LLC Is Investigating Paragon 28, Inc. (FNA) And Encourages Stockholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / February 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
medtechdive3d
Zimmer touts ASC opportunity with Paragon 28 purchase
With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...
Yahoo Finance3d
Zimmer touts ASC opportunity with Paragon 28 purchase
Zimmer Biomet executives expect the company’s planned $1.1 billion acquisition of Paragon 28 to give the company a larger presence in the growing market for procedures at ambulatory surgery ...
Paragon 28, Inc. (NYSE:FNA) Receives Average Rating of “Hold” from Analysts
Paragon 28, Inc. (NYSE:FNA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering the company, Ratings reports. Four research analysts have ...
Benzinga.com3d
Paragon 28 (NYSE:FNA) Stock, Short Interest Report
Short interest in Paragon 28 Inc (NYSE:FNA) increased during the last reporting period, rising from 3.54M to 3.73M. This put 7.94% of the company's publicly available shares short. Short interest ...
Yahoo Finance3d
Paragon 28, Inc. (FNA)
GLUE Monte Rosa Therapeutics, Inc.